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Abstract
Pregnancy is a time of transformation for both the mother and the baby, with 
significant physical and emotional changes. There are many discomforts that occur 
during pregnancy. Morning sickness, headache and backache, bladder and bowel 
changes, changes in hair and skin colour, indigestion and heartburn, leg cramps and 
swelling, vaginal thrush and discharge are the few common complications facing 
during pregnancy. As a result, the aim of this study was to describe the difficulties 
in obtaining health information and the measures to overcome the discomfort 
during pregnancy. Research articles for this review were searched by using the 
keywords “pregnancy”, health issues”, “measures to overcome”, “challenges”. There 
were studies that looked at the health problems that women face during pregnancy 
were included in this review article. Pregnancy issues such as gestational diabetes 
mellitus, hypertension, preeclampsia, caesarean birth, and postpartum weight 
retention are all more likely in overweight and obese women. More research into the 
link between nutritional advancements and the rising prevalence of GDM in the 
developing world is needed. Iron supplementation has been linked to glucose dys-
regulation and hypertension in mid-pregnancy; its effectiveness and potential risks 
should be carefully considered. As a result, legislators and health planners should 
remove barriers, promote self-care, and improve the quality of life for pregnant 
women, ultimately improving their health.
Keywords: Pregnancy, management, gestational diabetes, Preeclampsia, Anaemia
1. Introduction
Pregnancy is a time of transformation for both the mother and the baby, with 
significant physical and emotional changes. Even in uncomplicated pregnan-
cies, these improvements can impact pregnant women’s quality of life as well as 
maternal and child health. Women’s wellbeing, as well as their current level of 
understanding and knowledge, would undoubtedly have a significant impact on 
society [1]. Pregnant women need health information to improve their self-care 
skills and increase their empowerment when following preventive health habits. 
The cardiovascular system undergoes various changes as a result of pregnancy. A 
normal, healthy pregnant woman’s blood volume rises by nearly 50% over that of 
a non-pregnant woman. In addition, due to the vascular permeability associated 
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with extreme preeclampsia, efforts to increase blood volume in these patients have 
been unsuccessful [1, 2]. Pregnancy (critical care scenario) is the reduction in 
venous return to the heart and decrease in cardiac output associated with the supine 
position. This effect is obviously more pronounced in the third trimester, when the 
uterus is largest. The so-called supine hypotensive syndrome.
When treating a critically ill pregnant woman, various hematologic changes 
must be taken into account. During pregnancy, the thrombocyte count remains 
largely constant, it leads to thrombocytosis. These improvements, when combined 
with a decrease in fibrinolysis, lead to the hypercoagulable state of pregnancy. Deep 
vein thrombosis and pulmonary embolism are five times more common during 
and immediately after pregnancy [3]. Both the residual volume and the expiratory 
reserve volume decrease, resulting in an obligate reduction in functional residual 
capacity. During pregnancy, the vital ability remains the same. Because of the 
reduction in residual volume, total lung capacity is only slightly reduced. The reduc-
tion in residual volume has a minor impact on total lung capacity. The tidal volume 
is raised, resulting in an increase in minute volume [4]. Early in pregnancy, both 
renal plasma flow and glomerular filtration rate rise. The increase in glomerular 
filtration rate reaches 50%, lowering serum creatinine to 0.8 mg/dL, the upper 
limit of average. Only a few changes in the gastrointestinal tract during pregnancy 
are essential in terms of critical care. The time it takes for the stomach to clear and 
the chance of aspiration that comes with general anaesthesia are both increased 
during labour. Placental development may cause a significant increase in alkaline 
phosphatase, but this does not mean hepatic obstruction. Gallbladder stasis can lead 
to increased stone formation.
The liver is the primary source of net endogenous glucose development while 
not pregnant. Fasting glucose levels in pregnant women decline as the pregnancy 
progresses [5]. GDM is characterised as the presence of glucose concentrations in 
pregnant women that are at the upper end of the population range for glucose and 
are first observed during pregnancy [6]. Insulin sensitivity decreases overall during 
pregnancy. Maternal insulin sensitivity, characterised as a decrease in the glucose 
infusion rate during the euglycemic hyperinsulinemic clamp to maintain 90 mg/dL, 
decreases in lean women during early pregnancy [7]. Since lean women are more 
likely to begin their pregnancies with greater insulin sensitivity than obese women, 
the increases in insulin concentration are more pronounced in lean women [8]. 
During pregnancy, healthy pregnant women’s adipose tissue stores increase sig-
nificantly. The mother and foetus can easily obtain calories from the subcutaneous 
stores, particularly during late pregnancy and lactation. Increases in visceral fat can 
be linked to decreased insulin sensitivity during late pregnancy [9].
In their research, Das and Sarka found that pregnant women faced a variety of dif-
ficulties when seeking health information, including inadequate hospital treatment, 
long wait times, anxiety and shame about discussing pregnancy with a physician, 
and a lack of time [10]. There are many discomforts that occur during pregnancy. 
Morning sickness, headache and backache, bladder and bowel changes, changes in 
hair and skin colour, indigestion and heartburn, leg cramps and swelling, vaginal 
thrush and discharge are the few common complications facing during pregnancy. 
As a result, the aim of this study was to describe the difficulties in obtaining health 
information and the measures to overcome the discomfort during pregnancy.
2. Materials and methods
Research articles for this review were searched by using the keywords  
“pregnancy”, health issues”, “measures to overcome”, “challenges”. The following 
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were used as exclusion criteria: 1) the subject was unrelated to the study’s goal; 
2) there was no abstract available; 3) The research was limited to a single medical 
issue involving pregnancy in older women. 4) The report dealt with postpartum 
and maternity issues; and 5) the full research paper was not easily accessible. We 
looked for original research papers that were written in English and reported on 
studies that were performed using qualitative or quantitative methods. The current 
research did not include any other review papers. There were studies that looked at 
the health problems that women face during pregnancy were included in this review 
article.
3. Dental problems
According to previous literature, pregnant women’s dental health care demands 
differ dramatically from those of the general population. The most frequent oral 
health concerns during pregnancy include periodontal disease, Xerostomia, hali-
tosis, and tooth movement. During pregnancy, the hormonal balance of pregnant 
women alters. Because the placenta produces increased levels of oestrogen and 
progesterone during pregnancy, several tissues endure modifications. Increased 
sensitivity to irritations arises in the gingiva during this time [11]. Low vitamin C 
levels are thought to be another cause of this condition. When compared to mothers 
with healthy periodontium, mothers with attachment loss have an increased risk 
of giving birth to babies with low birth weight [12]. Tooth decay is more common 
among pregnant women for a variety of reasons, including increased acidity in the 
mouth, sweet food demands, and a lack of attention to oral health. Vomiting can 
have a severe impact on oral hygiene and induce degradation of the mother enamel 
layer [13]. Due to the effect of pregnancy hormones, pregnant women bleed more 
easily and may postpone brushing their teeth and it leads to an increase in bacterial 
plaque [14]. Due to diminished flow of saliva, caries are more likely to develop at 
this time. Pregnancy oral tumour is indistinguishable from pyogenic granuloma 
and occurs in up to 5% of pregnancies. Increased progesterone, in combination 
with local irritants and microorganisms, causes this vascular lesion [15]. With a 
prevalence of 60 to 75 percent, gingivitis is the most frequent dental illness among 
pregnant women. A severe aggravation of preexisting gingivitis occurs in around 
half of all pregnant women [16]. Researchers discovered very few oral bacteria in 
the amniotic fluid and placenta of women who had preterm labour with periodonti-
tis in one investigation [17]. PGE2 production reduces placental blood flow, result-
ing in placental necrosis and intrauterine growth restriction [18]. Salivary oestrogen 
levels are greater in women who are expecting preterm babies than in women who 
are expecting full-term babies. Salivary oestrogen promotes oral mucosa prolif-
eration and desquamation, as well as a rise in subgingival crevicular fluid levels. 
Desquamating cells offer a favourable environment for bacterial growth by supply-
ing nutrients, hence preventing infection [19].
3.1 Management
Oral acid exposure is reduced through dietary and lifestyle changes, as well as 
the use of antiemetics, antacids, or both. Acid can be neutralised by rinsing the 
mouth with a teaspoon of baking soda in a cup of water after vomiting [20]. To 
lessen the risk of enamel damage, pregnant women should be encouraged to avoid 
brushing their teeth shortly after vomiting and to brush with a toothbrush with soft 
bristles when they do. Fluoride mouthwash can protect teeth that have been eroded 
or are sensitive. Proper dental hygiene can help women with previous periodontal 
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disease lower the risk of recurrence or worsening disease during pregnancy. 
Education, clear communication, and the creation of continuing collaborative rela-
tionships can help physicians and dentists solve this dilemma. Physicians and dental 
colleagues can communicate information about the safety of dental treatment 
during pregnancy [21]. There is a link between plaque accumulation and caries 
prevalence during pregnancy and preventive maintenance methods. Mouthwashes 
or warm salty water should be gargled. Gums are relaxed and gum sensitivity is 
reduced by drinking warm salty water [22]. During this time, women can maintain 
their oral health by taking the required precautions, preventing potentially irrevers-
ible tooth disorders.
4. Hypertension
The mother’s cardiovascular physiology adapts significantly as a result of the 
hormonal changes that occur during pregnancy [23]. Oestrogen, progesterone, and 
relaxin levels rise early in the first trimester, resulting in systemic vasodilation [24]. 
The RAAS is activated to promote salt and water retention, resulting in an increase 
in plasma volume. When this is paired with an increase in ventricular wall mass, it 
results in greater stroke volume. During pregnancy, the combination of increased 
stroke volume and tachycardia causes an increase in cardiac output, which com-
pensates for the decrease in vascular resistance in order to keep blood pressure high 
enough for mother and placental perfusion [25]. The increased volume load in the 
heart causes left ventricular hypertrophy, which is proportional to the increased 
cardiac labour necessary to accomplish the increased cardiac output [26]. Some 
changes in the systemic hemodynamics of pregnant women who are predisposed 
to hypertension may occur before the condition manifests itself clinically. A sys-
tolic blood pressure of 160 mmHg or a diastolic blood pressure of 110 mmHg, or 
both, indicates severe preeclampsia in pregnancy. Eclampsia is a severe form of 
pregnancy-induced hypertension that affects one in every 1,600 pregnancies and 
appears at the end of the pregnancy [27]. When compared to singleton pregnancies, 
twin pregnancies had more than three times the risk of developing hypertension 
during pregnancy [28]. Preeclamptic patients have lower renin levels than non-
pregnant women, although they are still significantly higher than non-pregnant 
women. Because most preeclamptic individuals have a somewhat reduced plasma 
volume, maintaining relatively high levels of these hormones may be necessary [29].
Preeclampsia is the pathophysiology of de novo hypertension and proteinuria 
in pregnancy. The delivery of the placenta frequently triggers the remission of 
preeclampsia’s acute clinical symptoms, implying that the placenta plays a key role 
in the disease’s pathophysiology. The placenta undergoes substantial blood sup-
ply throughout normal pregnancy to allow circulation between the foetus and the 
mother [30]. The pathogenesis of preeclampsia has long been focused on altered 
uteroplacental blood flow. Relaxin is a hormone secreted more during pregnancy 
which acts as vasodilation. According to Jeyabalan et al., low first trimester relaxin 
concentrations were linked to an increased risk of preeclampsia [31].
4.1 Management
For non-severe hypertension in pregnancy, oral labetalol is a first-line treat-
ment [32]. Other beta-blockers, such as oxprenolol, are less thoroughly studied 
than labetalol, and it is used as a first-line treatment for non-severe hypertension 
in pregnancy [33]. In contrast, when oxprenolol was compared to methyldopa, 
the results and safety were found to be equal [34]. When mothers are exposed to 
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calcium channel blockers during the first trimester, there is low teratogenicity 
[35]. Elsewhere in pregnancy, ACE inhibitors are still the first-line treatment for 
hypertension [36]. For non-severe hypertension, thiazide diuretics are considered 
second-line therapy.
5. Gestational diabetes (GDM)
The prevalence of gestational diabetes mellitus (GDM) is rising in lockstep 
with the rise in overweight and obesity among women of childbearing age. GDM-
affected pregnancies increase the risk of caesarean and surgical vaginal delivery, 
macrosomia, neonatal hypoglycemia, and hyperbilirubinemia for both mother 
and child [37]. The onset of GDM is linked to a number of risk factors. Obesity, 
advanced maternal age, a significant family history of diabetes and belonging to 
an ethnic group are with a high prevalence of T2DM, polycystic ovarian syndrome, 
and chronic glucosuria. Because GDM usually starts in the late second trimester, 
when development is complete, congenital abnormalities do not occur at a higher 
rate in people with gestational diabetes. Because of the physiological, endocrine, 
and metabolic changes that occur throughout pregnancy in order to meet the fetus’s 
constant nutritional and oxygen needs, a diabetogenic condition comparable to type 
2 diabetes (T2D) develops, increasing insulin resistance, lowering insulin sensitivity, 
and thus increasing the demand for insulin [38]. As a result of the increased placen-
tal glucose transport, maternal hyperglycemia causes foetal hyperinsulinemia. Foetal 
macrosomia is caused by a high insulin level in the foetus, which accelerates growth 
[39]. Although glucose metabolism changes during pregnancy, tolerance occurs and 
there is no effect on the mother or the foetus when insulin production rises. There is 
a higher risk of foetal when there is an inappropriate response. When the output of 
the pancreatic b-cells does not match the insulin requirement of the tissues as a result 
of alterations in insulin resistance, abnormal glucose tolerance ensues [40]. Early in 
pregnancy, fasting blood glucose levels drop, and this trend continues throughout 
the pregnancy. Insulin sensitivity decreases as pregnancy progresses, reaching pre-
gravid levels about 34–36 weeks of pregnancy [40, 41]. Increases in hepatic glucose 
production during pregnancy show that the insulin action deficiency also affects 
the liver. Placental loss of anti-insulin hormones such as human placental lactogen, 
cortisol, oestrogen, and progesterone causes insulin resistance after mid-pregnancy. 
Low FBS, a low kidney glucose threshold, and enhanced insulin production are all 
effects of these hormones [42]. Maternal tissues become increasingly insulin resis-
tant during pregnancy. This is thought to be produced in part by placental hormones 
and in part by unknown obesity and pregnancy-related variables. The main locations 
for glucose disposal throughout the body are skeletal muscle and adipose tissue. 
Insulin-mediated whole-body glucose elimination declines by 50% during preg-
nancy, and the woman must raise her insulin output by 200–250 percent to maintain 
a euglycemic condition [43]. Even while most women revert to a euglycaemic state 
immediately after delivery, women who have had GDM have a significantly higher 
chance of developing T2DM [44]. The biochemical relationship between GDM and 
T2DM is still unknown. Insulin resistance and/or aberrant insulin production define 
both illnesses [45]. Multiple potential protein indicators for later GDM have been 
discovered through proteomic screening in early pregnancy, including a cluster 
linked with insulin production, binding, resistance, and signalling [46]. An oral 
glucose tolerance test (OGTT) is usually used to identify GDM during 24–28 weeks 
of pregnancy. Because most of the physiologic insulin resistance of pregnancy will 
be firmly established, this timeframe has traditionally been favoured for routine 
GDM diagnosis. Another important difference in GDM testing techniques around 
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the world is the ongoing debate over whether testing should be universal (for all 
pregnant women) or targeted solely for women with risk factors linked to a higher 
probability of a positive result.
5.1 Management
Preventive interventions are needed to avoid the undesired consequences of obe-
sity and hyperglycemia during pregnancy, given the global rise in obesity and the 
resulting increase in GDM [38, 47]. In roughly 70 to 85 percent of women with diag-
nosed GDM, lifestyle changes are enough to meet glycemic objectives [48]. Dietary 
counselling, in combination with physical activity and blood glucose self-monitor-
ing, is the major intervention indicated for GDM [49]. A lower-carbohydrate diet 
with more animal protein and fat enhanced the risk of type 2 diabetes. As a result, 
it’s possible that the diet that’s best for treating GDM in women is not the best 
long-term diet [50]. Other nutritional treatments, such as probiotics and vitamin 
supplements, have gained popularity, but there is not enough data to suggest their 
widespread usage [51]. Insulin therapy is the preferred treatment because it does 
not cross the placenta and is thus deemed safe for the foetus. Metformin therapy 
was deemed safe and effective, and the women preferred it for insulin treatment 
[52]. Another study states that Metformin and sulfonylurea have been increasingly 
and safely used in the treatment of GDM [53]. In diabetic pregnant women with 
vitamin D deficiency/insufficiency, vitamin D administration can lower the chance 
of developing GDM and/or improve glycemic control [54]. Vitamin D regulates 
intracellular calcium to promote insulin production and attenuates insulin resis-
tance by acting directly on pancreatic beta cells via the development of vitamin D 
receptors and the enzyme 25(OH)D-1-alfa-hydroxylase [55]. Furthermore, recent 
evidence from a large prospective trial suggests that increased physical activity may 
help reduce the risk of T2DM progression [56]. Exercise activities did not have a sig-
nificant influence on the overall incidence of GDM in obese or overweight pregnant 
women, but when the effect measure was taken into account, the incidence of GDM 
was 24 percent lower in that group [57]. The following five components of guideline 
content were examined: GDM diagnosis, prenatal care, intrapartum care, neonatal 
care, and postpartum care. The majority of the suggestions in the guidelines were 
on prenatal care, particularly all types of therapy that could lower the risk of bad 
pregnancy outcomes due to uncontrolled blood sugar prior to conception [58]. The 
usage of information technology and digital platforms by diabetic pregnant women 
is fast rising around the world [59]. Telemedicine has been linked to high patient 
satisfaction since it allows for quick management of care across distances with 
fewer face-to-face physician appointments [60]. As a result, the use of e-platforms 
in the management of gestational diabetes shows encouraging results in terms of 
patient satisfaction and has no negative impact on pregnancy outcomes. Adequately 
powered RCTs are needed to assess whether such healthcare technologies are cost-
effective or can help enhance care in urban or distant settings [61].
6. Gestational thrombocytopenia and anaemia
During pregnancy, several biological markers, particularly haematological, 
are physiologically altered. Biologists and doctors who are aware of these changes 
in the maternal body can screen for potential abnormalities. The haematological 
parameters must adjust in several ways, including providing vitamins and miner-
als for foetal haematopoiesis (iron, vitamin B12, folic acid), which can increase 
maternal anaemia, and preparing for birth bleeding, which is necessary to improve 
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homeostasis [62]. The total blood volume increases by roughly 1.5 litres during 
pregnancy, primarily to meet the demands of the new vascular bed and to com-
pensate for blood loss that occurs during birth [63]. At 6–12 weeks of pregnancy, 
the plasma volume expands by 10–15 percent. When maternal erythropoietin 
production rises, RBC mass rises as well, albeit at a slower rate than plasma volume, 
resulting in a drop in haemoglobin concentration. Dilutional anaemia is the result 
[64]. Haemodilution also contributes to a decrease in the rate of haematocrit (HCT) 
and haemoglobin (HGB), resulting in a false anaemia. Such a change is natural for 
pregnant women and demonstrates the adoption of a different threshold for the 
definition of pregnancy anaemia. The WHO defines anaemia in pregnancy as hav-
ing a total circulating HGB concentration of less than 11 g/dl or an HCT of less than 
33% at any point during the pregnancy. During pregnancy, RBC indices do not vary 
much. However, in an iron-replete woman, there is a slight rise in mean corpuscular 
volume (MCV) of around 4 fl, which peaks around 30–35 weeks gestation and does 
not indicate a vitamin B12 or folate shortage. The increased MCV can be explained 
by increased RBC production to fulfil the demands of pregnancy [65]. The haemo-
globin concentration does not change until the 16th week of pregnancy, after which 
it falls steadily to the second trimester due to the expansion of plasma volume [66]. 
Haemodilution, or an increase in plasma volume greater than an increase in red cell 
mass, is the underlying cause of anaemia during pregnancy. This condition is also 
known as ‘physiological anaemia of pregnancy’ [67]. Because length is more stable 
than weight, haemoglobin demonstrated a positive connection with infant length 
but not with weight [68]. Haemoglobin and haematocrit increased on the first day 
after birth, decreased on the third and fifth days, and then began to rise again by 
day 42, achieving normal haemoglobin in non-pregnant women [69]. Because of the 
greater metabolic oxygen requirement, erythropoietin levels are 50 percent greater, 
which explains the mild bone marrow erythroid hyperplasia and enhanced reticu-
locyte count. A combination of a lowered maternal RBCs oxygen affinity from an 
enhanced 2,3 Diphosphoglycerate and a low maternal pCO2 results in enhanced 
oxygen transfer throughout the placenta [70].
Pregnancy causes an increase in white blood cell count, with the lowest limit of the 
reference range typically being 6,000/cumm. Leucocytosis occurs during pregnancy 
as a result of the physiologic stress that comes with being pregnant [71]. Throughout 
the first and second trimesters of pregnancy, lymphocyte count drops, then rises 
during the third trimester. Total leukocyte count levels rise significantly in the II and 
III trimesters, but there is no difference between pregnant and non-pregnant women 
in the I trimester. In the first trimester of pregnancy, non-anaemic women have a 
higher TLC count than anaemic women, but in the second and third trimesters, 
anaemic women have a higher TLC count than non-anaemic women [62]. During 
normal pregnancy, leukocytosis is caused by an enhanced inflammatory response, 
which can be caused by selective immunological tolerance, immunosuppression, and 
immunomodulation of the foetus [72]. During pregnancy, the ratio of monocytes to 
lymphocytes rises dramatically. During pregnancy, however, eosinophil and basophil 
numbers do not alter appreciably [73]. The neutrophil count starts to rise in the sec-
ond month of pregnancy and reaches a plateau in the second or third trimester, when 
total white blood cell counts range from 9,000 to 15,000 cells per microliter.
In 7–8 percent of all pregnancies, gestational thrombocytopenia occurs. Due to 
rapid degradation, platelet counts are slightly lower which results in younger, bigger 
platelets present in pregnancy. The majority of thrombocytopenia in pregnancy 
is caused by increased blood loss [74]. Although the average platelet count falls 
monotonically during pregnancy, platelet aggregation increases, notably during the 
last 8 weeks of pregnancy [75]. The decline in the quantity of circulating platelets 
during pregnancy has been attributed to increased platelet consumption as well as a 
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shorter life span in the uteroplacental circulation [76]. As the pregnancy progresses, 
the platelet volume distribution width widens dramatically and continually. As a 
result, as pregnancy progresses, the mean platelet volume becomes an insensitive 
indicator of platelet size.
Primary immune thrombocytopenia (ITP) affects about 3% of women who are 
thrombocytopenic at delivery. It occurs in 1/1000–1/10 000 pregnancies [77]. Two-
thirds of women with ITP have pre-existing disease, according to most studies, and 
one-third are diagnosed for the first time during pregnancy [78]. The pathophysi-
ological mechanism of thrombotic thrombocytopenic purpura (TTP) is thrombotic 
microangiopathy. Microangiopathic hemolytic anaemia, thrombocytopenia, fever, 
neurological signs, and renal impairment are all symptoms of TTP. Pregnancy is 
thought to be the trigger event in between 5 to 25% of TTP cases [79]. TTP occurs 
in the second trimester of pregnancy and occasionally in the postpartum period, 
although it is uncommon in the first trimester [80]. If TTP appears during the first 
trimester, regular plasma exchange may be able to maintain pregnancy.
6.1 Management
Preventing anaemia in pregnancy requires effective communication about diet and 
nutrition to all pregnant women. Most experts recommend regular iron supplementa-
tion during pregnancy since the extra demand for iron is typically unmet by a typical 
diet. Although iron supplementation recommendations vary by location, the CDC 
recommends that all pregnant women begin a 30 mg/day iron supplementation [81]. 
he average iron density in a typical Indian diet is 8.5 mg/1000 Kcal, with 13.3 and 5.3 
percent iron absorption in pregnancy from a rice-based and wheat-based Indian diet, 
respectively [82]. Women can use smartphone applications to learn about their daily 
iron needs, the iron content of various foods, and how to track their dietary iron intake. 
We support the creation and use of such applications. For improved absorption, all 
pregnant women should be told to take oral iron on an empty stomach or 1 hour after 
meals, preferably with a vitamin C-rich product like orange juice or guava. Supplement 
2 outlines the oral iron treatments that can be used during pregnancy [82, 83].
The choice of therapy is based on the urgency of the platelet increase, the 
duration of the increase, and any potential side effects, and should be determined 
on an individual basis for each patient. Platelets should be available on standby if 
the mother’s platelet count remains low (50 109/l) around the time of delivery, but 
they are likely to be destroyed rapidly after infusion if due to an immune reac-
tion, so they should be given in well-established rather than early labour if there 
are increased bleeding complications [84]. Given that there is no evidence that 
Caesarean delivery is safer for the foetus with thrombocytopenia than a simple 
vaginal delivery, which is usually safer than caesarean for the mother, the mode of 
delivery should be decided on obstetric concerns. Treatment may be required just 
during the later part of the third trimester to boost the platelet level before epidural 
anaesthesia or C section section if the individual is asymptomatic and the platelet 
count is more than 20*109/L [85]. Depending on the platelet level and stability, 
general measures such as avoiding aspirin, nonsteroidal anti-inflammatory medica-
tions, and intramuscular injections might be explored. Because low-dose aspirin is 
now commonly administered in pregnancy for a variety of reasons, it should not be 
avoided unless the risk of bleeding is significant. Prednisone at a low dose or intra-
venous immunoglobulin, or both, are viable alternatives in these circumstances. 
In symptomatic pregnant ITP patients or if the platelet count is less than standard 
level, other therapeutic options are available. When combined with intravenous 
immunoglobulin, a large dose of steroids can be employed [86]. Corticosteroids and 
intravenous IVIG are the most common treatments for maternal ITP [87].
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7. Conclusion
When it came to getting health information, pregnant women faced personal, 
societal, and structural challenges. As a result, legislators and health planners 
should remove barriers, promote self-care, and improve the quality of life for 
pregnant women, ultimately improving their health. Pregnancy issues such as ges-
tational diabetes mellitus, hypertension, preeclampsia, caesarean birth, and post-
partum weight retention are all more likely in overweight and obese women. More 
research into the link between nutritional advancements and the rising prevalence 
of GDM in the developing world is needed. Iron supplementation has been linked 
to glucose dysregulation and hypertension in mid-pregnancy; its effectiveness and 
potential risks should be carefully considered.
Acknowledgements
I would like to thank Saveetha Institute of Medical and Technical Sciences for 
giving me this opportunity to carry out the research work.
Funding Support
This study received no specific support from public, private, or non-profit  
funding bodies.
Conflict of interest
No potential conflict of interest relevant to this article was reported.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
10
Global Women’s Health
[1] Jung J, Horta H, Yonezawa A. 
Researching Higher Education in Asia: 
History, Development and Future. 
Springer; 2017. 366 p.
[2] Pritchard JA. Changes in the Blood 
Volume During Pregnancy and Delivery 
[Internet]. Vol. 26, Anesthesiology. 1965. p. 
393-9. Available from: http://dx.doi.
org/10.1097/00000542-196507000-00004
[3] Toglia MR, Weg JG. Venous 
Thromboembolism during Pregnancy 
[Internet]. Vol. 335, New England 





[6] Catalano PM, Huston L, Amini SB, 
Kalhan SC. Longitudinal changes in 
glucose metabolism during pregnancy 
in obese women with normal glucose 
tolerance and gestational diabetes 
mellitus [Internet]. Vol. 180, American 
Journal of Obstetrics and Gynecology. 
1999. p. 903-16. Available from: http://
dx.doi.org/10.1016/
s0002-9378(99)70662-9
[7] Catalano PM, Tyzbir ED, Wolfe RR, 
Calles J, Roman NM, Amini SB, et al. 
Carbohydrate metabolism during 
pregnancy in control subjects and 
women with gestational diabetes 
[Internet]. Vol. 264, American Journal 
of Physiology-Endocrinology and 
Metabolism. 1993. p. E60-7. Available 
from: http://dx.doi.org/10.1152/
ajpendo.1993.264.1.e60
[8] Lain KY, Catalano PM. Metabolic 
changes in pregnancy. Clin Obstet 
Gynecol. 2007 Dec;50(4):938-948.
[9] Kitzmiller J, Jovanovic L, Brown F, 
Coustan D. Managing Preexisting 
Diabetes and Pregnancy: Technical 
Reviews and Consensus 
Recommendations for Care. American 
Diabetes Association; 2008. 852 p.
[10] Das A, Sarkar M. Pregnancy-related 
health information-seeking behaviors 
among rural pregnant women in India: 
validating the Wilson model in the 
Indian context. Yale J Biol Med. 2014 
Sep;87(3):251-262.
[11] Dörtbudak O, Eberhardt R, Ulm M, 
Persson GR. Periodontitis, a marker of 
risk in pregnancy for preterm birth. J 
Clin Periodontol. 2005 Jan;32(1):45-52.
[12] Offenbacher S. Maternal 
Periodontal Infections, Prematurity, 
and Growth Restriction [Internet]. Vol. 
47, Clinical Obstetrics and Gynecology. 
2004. p. 808-21. Available from: http://
dx.doi.org/10.1097/01.
grf.0000141894.85221.f7
[13] Silk H, Douglass AB, Maier R, 
Clark M, Deutchman M, Douglass J, et 
al. Smiles for Life National Oral Health 
Curriculum: Module 5. Oral Health in 
Pregnancy [Internet]. Vol. 8, 
MedEdPORTAL. 2012. Available from: 
http://dx.doi.org/10.15766/
mep_2374-8265.9259
[14] Website [Internet]. [cited 2021 May 
26]. Available from: https://doi.
org/10.4103/0976-9668.166124
[15] Sills ES, Zegarelli DJ, 
Hoschander MM, Strider WE. Clinical 
diagnosis and management of 
hormonally responsive oral pregnancy 
tumor (pyogenic granuloma). J Reprod 
Med. 1996 Jul;41(7):467-470.
[16] Website [Internet]. [cited 2021 May 
26]. Available from: American Dental 
Association Council on Access, 
Prevention and Interprofessional 
Relations. Women’s oral health issues. 




Challenges Facing during Pregnancy and Measures to Overcome
DOI: http://dx.doi.org/10.5772/intechopen.100614
topics/healthcare_womens.pdf. 
Accessed August 1, 2007.
[17] Goepfert AR, Jeffcoat MK, 
Andrews WW, Faye-Petersen O, 
Cliver SP, Goldenberg RL, et al. 
Periodontal Disease and Upper Genital 
Tract Inflammation in Early Spontaneous 
Preterm Birth [Internet]. Vol. 104, 
Obstetrics & Gynecology. 2004. p. 
777-83. Available from: http://dx.doi.
org/10.1097/01.aog.0000139836.47777.6d
[18] Offenbacher S, Lieff S, Boggess KA, 
Murtha AP, Madianos PN, 
Champagne CME, et al. Maternal 
Periodontitis and Prematurity. Part I: 
Obstetric Outcome of Prematurity and 
Growth Restriction [Internet]. Vol. 6, 
Annals of Periodontology. 2001. p. 
164-74. Available from: http://dx.doi.
org/10.1902/annals.2001.6.1.164
[19] Lopez BC, Chaveli Lopez B, 
Perez MGS, Jimenez Soriano Y. Dental 
considerations in pregnancy and 
menopause [Internet]. Journal of 
Clinical and Experimental Dentistry. 
2011. p. e135-44. Available from: http://
dx.doi.org/10.4317/jced.3.e135
[20] Wright GZ, Kupietzky A. Behavior 
Management in Dentistry for Children. 
John Wiley & Sons; 2014. 264 p.
[21] Livingston HM, Mark Livingston H, 
Dellinger TM, Holder R. Considerations 
in the management of the pregnant 
patient [Internet]. Vol. 18, Special Care 
in Dentistry. 1998. p. 183-8. Available 
from: http://dx.doi.org/10.1111/j.1754- 
4505.1998.tb01737.x
[22] Zanata RL, Navarro MF de L, 
Pereira JC, Franco EB, Lauris JRP, 
Barbosa SH. Effect of caries preventive 
measures directed to expectant mothers 
on caries experience in their children. 
Braz Dent J. 2003 Oct 3;14(2):75-81.
[23] Sanghavi M, Rutherford JD. 
Cardiovascular Physiology of Pregnancy 
[Internet]. Vol. 130, Circulation. 2014. 
p. 1003-8. Available from: http://dx.doi.
org/10.1161/circulationaha.114.009029
[24] Kodogo V, Azibani F, Sliwa K. Role 
of pregnancy hormones and hormonal 
interaction on the maternal 
cardiovascular system: a literature 
review. Clin Res Cardiol. 2019 
Aug;108(8):831-846.
[25] Ngene NC, Moodley J. Physiology of 
blood pressure relevant to managing 
hypertension in pregnancy. J Matern 
Fetal Neonatal Med. 2019 
Apr;32(8):1368-1377.
[26] Simmons LA, Gillin AG, 
Jeremy RW. Structural and functional 
changes in left ventricle during 
normotensive and preeclamptic 
pregnancy [Internet]. Vol. 283, 
American Journal of Physiology-Heart 
and Circulatory Physiology. 2002. p. 
H1627-33. Available from: http://dx.doi.
org/10.1152/ajpheart.00966.2001
[27] L. PK, Professor A,  
Permi HS, V. MS, Guruprasad Y, 
Professor A, et al. Study of Biochemical 
Parameters in Pregnancy Induced 
Hypertension (PIH) [Internet]. Vol. 5, 
Indian Journal of Pathology: Research 
and Practice. 2016. p. 191-4. Available 
from: http://dx.doi.org/10.21088/
ijprp.2278.148x.5216.21
[28] Tessema GA, Tekeste A, Ayele TA. 
Preeclampsia and associated factors 
among pregnant women attending 
antenatal care in Dessie referral 
hospital, Northeast Ethiopia: a hospital-
based study [Internet]. Vol. 15, BMC 
Pregnancy and Childbirth. 2015. 
Available from: http://dx.doi.
org/10.1186/s12884-015-0502-7
[29] Luft FC, Eileen D. M. Gallery, 
Lindheimer MD. Normal and Abnormal 
Volume Homeostasis [Internet]. 
Chesley’s Hypertensive Disorders in 





[30] Agarwal I, Ananth Karumanchi S. 
Preeclampsia and the anti-angiogenic 
state [Internet]. Vol. 1, Pregnancy 
Hypertension: An International Journal 
of Women’s Cardiovascular Health. 
2011. p. 17-21. Available from: http://
dx.doi.org/10.1016/j.preghy.2010.10.007
[31] Tregear GW, Ivell R, Bathgate RA, 
Wade JD. Relaxin 2000. Springer 
Science & Business Media; 2001. 460 p.
[32] Tranquilli AL, Dekker G, Magee L, 
Roberts J, Sibai BM, Steyn W, et al. The 
classification, diagnosis and 
management of the hypertensive 
disorders of pregnancy: A revised 
statement from the ISSHP [Internet]. 
Vol. 4, Pregnancy Hypertension: An 
International Journal of Women’s 
Cardiovascular Health. 2014. p. 97-104. 
Available from: http://dx.doi.
org/10.1016/j.preghy.2014.02.001
[33] Redman CWG. Hypertension in 
pregnancy: the NICE guidelines 
[Internet]. Vol. 97, Heart. 2011. p. 
1967-9. Available from: http://dx.doi.
org/10.1136/heartjnl-2011-300949
[34] Fidler J, Smith V, Fayers P, De 
Swiet M. Randomised controlled 
comparative study of methyldopa and 
oxprenolol in treatment of hypertension 
in pregnancy [Internet]. Vol. 286, BMJ. 
1983. p. 1927-30. Available from: http://
dx.doi.org/10.1136/bmj.286.6382.1927
[35] Magee LA, Schick B, 
Donnenfeld AE, Sage SR, Conover B, 
Cook L, et al. The safety of calcium 
channel blockers in human pregnancy: a 
prospective, multicenter cohort study. 
Am J Obstet Gynecol. 1996 
Mar;174(3):823-828.
[36] Guideline for the Diagnosis and 
Management of Hypertension in Adults. 
2016. 74 p.
[37] Catalano PM, Ehrenberg HM. 
Review article: The short- and long-
term implications of maternal obesity 
on the mother and her offspring 
[Internet]. Vol. 113, BJOG: An 
International Journal of Obstetrics & 
Gynaecology. 2006. p. 1126-33. 
Available from: http://dx.doi.
org/10.1111/j.1471-0528.2006.00989.x
[38] Mottola MF, Artal R. Role of 
Exercise in Reducing Gestational 
Diabetes Mellitus [Internet]. Vol. 59, 
Clinical Obstetrics & Gynecology. 2016. 
p. 620-8. Available from: http://dx.doi.
org/10.1097/grf.0000000000000211
[39] The Pregnant Diabetic and Her 
Newborn. Problems and Management 
[Internet]. Vol. 43, Archives of Disease 
in Childhood. 1968. p. 391-391. 
Available from: http://dx.doi.
org/10.1136/adc.43.229.391-a
[40] Kim C, Ferrara A. Gestational 
Diabetes During and After Pregnancy. 
Springer Science & Business Media; 
2010. 394 p.
[41] Catalano PM, Tyzbir ED, 
Roman NM, Amini SB, Sims EAH. 
Longitudinal changes in insulin release 
and insulin resistance in nonobese 
pregnant women [Internet]. Vol. 165, 
American Journal of Obstetrics and 
Gynecology. 1991. p. 1667-72. Available 
from: http://dx.doi.
org/10.1016/0002-9378(91)90012-g
[42] A review article- gestational 
diabetes mellitus. Int J Endocrinol 
Metab. 2019 Feb 7;7(1):62-5.
[43] Barbour LA, McCurdy CE, 
Hernandez TL, Kirwan JP, Catalano PM, 
Friedman JE. Cellular Mechanisms for 
Insulin Resistance in Normal Pregnancy 
and Gestational Diabetes [Internet]. 
Vol. 30, Diabetes Care. 2007. p. S112-9. 
Available from: http://dx.doi.
org/10.2337/dc07-s202
[44] Bellamy L, Casas J-P, Hingorani AD, 
Williams D. Type 2 diabetes mellitus 
after gestational diabetes: a systematic 
review and meta-analysis [Internet]. 
13
Challenges Facing during Pregnancy and Measures to Overcome
DOI: http://dx.doi.org/10.5772/intechopen.100614
Vol. 373, The Lancet. 2009. p. 1773-9. 
Available from: http://dx.doi.
org/10.1016/s0140-6736(09)60731-5
[45] Lauenborg J, Grarup N, Damm P, 
Borch-Johnsen K, Jørgensen T, 
Pedersen O, et al. Common type 2 
diabetes risk gene variants associate 
with gestational diabetes. J Clin 
Endocrinol Metab. 2009 
Jan;94(1):145-150.
[46] Zhou T, Huang L, Wang M, Chen D, 
Chen Z, Jiang S-W. A Critical Review of 
Proteomic Studies in Gestational 
Diabetes Mellitus. J Diabetes Res. 2020 
Jul 14;2020:6450352.
[47] Bain E, Crane M, Tieu J, Han S, 
Crowther CA, Middleton P. Diet and 
exercise interventions for preventing 
gestational diabetes mellitus [Internet]. 
Cochrane Database of Systematic 
Reviews. 2015. Available from: http://
dx.doi.org/10.1002/14651858.
cd010443.pub2
[48] Association AD, American Diabetes 
Association. 13. Management of 
Diabetes in Pregnancy:Standards of 
Medical Care in Diabetes—2018 
[Internet]. Vol. 41, Diabetes Care. 2018. 
p. S137-43. Available from: http://dx.doi.
org/10.2337/dc18-s013
[49] Lapolla A, Fedele D, Dalfra. 
Management of gestational diabetes 
mellitus [Internet]. Vol. 2, Diabetes, 
Metabolic Syndrome and Obesity: 
Targets and Therapy. 2009. p. 73-82. 
Available from: http://dx.doi.
org/10.2147/dmso.s3407
[50] Bao W, Li S, Chavarro JE, 
Tobias DK, Zhu Y, Hu FB, et al. Low 
Carbohydrate–Diet Scores and Long-
term Risk of Type 2 Diabetes Among 
Women With a History of Gestational 
Diabetes Mellitus: A Prospective 
Cohort Study [Internet]. Vol. 39, 
Diabetes Care. 2016. p. 43-9. Available 
from: http://dx.doi.org/10.2337/
dc15-1642
[51] Dolatkhah N, Hajifaraji M, 
Abbasalizadeh F, 
Aghamohammadzadeh N, Mehrabi Y, 
Abbasi MM. Is there a value for 
probiotic supplements in gestational 
diabetes mellitus? A randomized clinical 
trial [Internet]. Vol. 33, Journal of 
Health, Population and Nutrition. 2015. 
Available from: http://dx.doi.
org/10.1186/s41043-015-0034-9
[52] Rowan JA, Hague WM, Gao W, 
Battin MR, Peter Moore M. Metformin 
versus Insulin for the Treatment of 
Gestational Diabetes [Internet]. Vol. 
358, New England Journal of Medicine. 
2008. p. 2003-15. Available from: http://
dx.doi.org/10.1056/nejmoa0707193
[53] Dhulkotia JS, Ola B, Fraser R, 
Farrell T. Oral hypoglycemic agents vs 
insulin in management of gestational 
diabetes: a systematic review and 
metaanalysis. Am J Obstet Gynecol. 
2010 Nov;203(5):457.e1-9.
[54] Poel YHM, Hummel P, Lips P, 
Stam F, van der Ploeg T, Simsek S. 
Vitamin D and gestational diabetes: a 
systematic review and meta-analysis. 
Eur J Intern Med. 2012 
Jul;23(5):465-469.
[55] Alvarez JA, Ashraf A. Role of 
vitamin d in insulin secretion and 
insulin sensitivity for glucose 
homeostasis. Int J Endocrinol. 
2010;2010:351385.
[56] Bao W, Tobias DK, Bowers K, 
Chavarro J, Vaag A, Grunnet LG, et al. 
Physical activity and sedentary 
behaviors associated with risk of 
progression from gestational diabetes 
mellitus to type 2 diabetes mellitus: a 
prospective cohort study. JAMA Intern 
Med. 2014 Jul;174(7):1047-1055.
[57] Nasiri-Amiri F, Sepidarkish M, 
Shirvani MA, Habibipour P, 
Tabari NSM. The effect of exercise on 
the prevention of gestational diabetes in 
obese and overweight pregnant women: 
Global Women’s Health
14
a systematic review and meta-analysis. 
Diabetol Metab Syndr. 2019 Aug 
27;11:72.
[58] Mahmud M, Mazza D. 
Preconception care of women with 
diabetes: a review of current guideline 
recommendations. BMC Womens 
Health. 2010 Jan 31;10:5.
[59] Diabetes Canada Clinical Practice 
Guidelines Expert Committee, Feig DS, 
Berger H, Donovan L, Godbout A, 
Kader T, et al. Diabetes and Pregnancy. 
Can J Diabetes. 2018 Apr;42 Suppl 
1:S255-82.
[60] Ivey TL, Hughes D, Dajani NK, 
Magann EF. Antenatal management of 
at-risk pregnancies from a distance. 
Aust N Z J Obstet Gynaecol. 2015 
Feb;55(1):87-89.
[61] Mitric C, Desilets J, Brown RN. 
Recent advances in the antepartum 
management of diabetes. F1000Res. 
2019 May 8;8(622):622.
[62] Mohamed A, Hamza K, Babker A. 
Physiological changes in some 
hematological and coagulation profile 
among Sudanese healthy pregnant 
women [Internet]. Vol. 5, International 
Journal of Medical Science and Public 
Health. 2016. p. 525. Available from: 
http://dx.doi.org/10.5455/
ijmsph.2016.30092015149
[63] Ramsay M. Normal hematological 
changes during pregnancy and the 
puerperium [Internet]. The Obstetric 
Hematology Manual. p. 3-12. Available 
from: http://dx.doi.org/10.1017/
cbo9780511676451.002
[64] Bernstein IM, Ziegler W, Badger GJ. 
Plasma Volume Expansion in Early 
Pregnancy [Internet]. Vol. 97, Obstetrics 




[65] Taylor DJ, Lind T. Red cell mass 
during and after normal pregnancy. Br J 
Obstet Gynaecol. 1979 
May;86(5):364-370.
[66] Micronutrient Initiative, 
Gallego EB, International Development 
Research Centre (Canada). Severe 
Anemia in Pregnancy: Report of a 
Workshop Held at the Institute of Child 
and Mother Health in Dhaka, 
Bangladesh. L’Initiative 
micronutriments = Micronutrient 
Initiative; 2000. 31 p.
[67] P S, Sharma P, Research Scholar, 
Department of Home Science, 
University of Rajasthan, Jaipur. 
Hematological profile of anemic 
pregnant women attending antenatal 
hospital [Internet]. Vol. 1, IOSR Journal 
of Nursing and Health Science. 2013. p. 
11-5. Available from: http://dx.doi.
org/10.9790/1959-0141115
[68] Weerd S de, de Weerd S, 
Steegers-Theunissen RPM, de Boo TM, 
Thomas CMG, Steegers EAP. Maternal 
periconceptional biochemical and 
hematological parameters, vitamin 
profiles and pregnancy outcome 
[Internet]. Vol. 57, European Journal of 
Clinical Nutrition. 2003. p. 1128-34. 
Available from: http://dx.doi.
org/10.1038/sj.ejcn.1601654
[69] Ramakers C, Van Der WOUDE 
DAA, Verzijl JM, Pijnenborg JMA, Van 
WIJK EM. An added value for the 
hemoglobin content in reticulocytes 
(CHr) and the mean corpuscular 
volume (MCV) in the diagnosis of iron 
deficiency in postpartum anemic 
women [Internet]. Vol. 34, International 
Journal of Laboratory Hematology. 
2012. p. 510-6. Available from: http://
dx.doi.
org/10.1111/j.1751-553x.2012.01423.x
[70] Madsen H, Ditzel J. Red cell 
2,3-diphosphoglycerate and 
hemoglobin--oxygen affinity during 
15
Challenges Facing during Pregnancy and Measures to Overcome
DOI: http://dx.doi.org/10.5772/intechopen.100614
normal pregnancy. Acta Obstet Gynecol 
Scand. 1984;63(5):399-402.
[71] Akinlaja O. Hematological Changes 
in Pregnancy - The Preparation for 
Intrapartum Blood Loss [Internet]. Vol. 
4, Obstetrics & Gynecology 
International Journal. 2016. Available 
from: http://dx.doi.org/10.15406/
ogij.2016.04.00109
[72] Osonuga IO, Osonuga OA, 
Onadeko AA, Osonuga A, Osonuga AA. 
Hematological profile of pregnant 
women in southwest of Nigeria 
[Internet]. Vol. 1, Asian Pacific Journal 
of Tropical Disease. 2011. p. 232-4. 
Available from: http://dx.doi.
org/10.1016/s2222-1808(11)60036-4
[73] Edelstam G, Löwbeer C, Kral G, 
Gustafsson SA, Venge P. New reference 
values for routine blood samples and 
human neutrophilic lipocalin during 
third-trimester pregnancy. Scand J Clin 
Lab Invest. 2001;61(8):583-592.
[74] Eledo BO. Evaluation of Some 
Haematological Parameters Among 
Post-menopausal Women in Bayelsa 
State, Nigeria: A Case Study of Patients 
Attending Federal Medical Centre, 
Yenagoa [Internet]. Vol. 2, American 
Journal of Laboratory Medicine. 2017. p. 
132. Available from: http://dx.doi.
org/10.11648/j.ajlm.20170206.14
[75] Fay RA, Hughes AO, Farron NT. 
Platelets in pregnancy: hyperdestruction 
in pregnancy. Obstet Gynecol. 1983 
Feb;61(2):238-240.
[76] Ahmed Y, Van Iddekinge B, Paul C, 
Sullivan MHF, Elder MG. 
Retrospective analysis of platelet 
numbers and volumes in normal 
pregnancy and in pre-eclampsia 
[Internet]. Vol. 43, International 
Journal of Gynecology & Obstetrics. 
1993. p. 230-230. Available from: 
http://dx.doi.org/10.1016/0020- 
7292(93)90342-t
[77] Gill KK, Kelton JG. Management of 
idiopathic thrombocytopenic purpura in 
pregnancy [Internet]. Vol. 37, Seminars 
in Hematology. 2000. p. 275-89. 
Available from: http://dx.doi.
org/10.1053/shem.2000.8960
[78] Webert KE, Mittal R, Sigouin C, 
Heddle NM, Kelton JG. A retrospective 
11-year analysis of obstetric patients 
with idiopathic thrombocytopenic 
purpura. Blood. 2003 Dec 
15;102(13):4306-4311.
[79] Vesely SK, Li X, McMinn JR, 
Terrell DR, George JN. Pregnancy 
outcomes after recovery from 
thrombotic thrombocytopenic purpura-
hemolytic uremic syndrome [Internet]. 
Vol. 44, Transfusion. 2004. p. 1149-58. 
Available from: http://dx.doi.
org/10.1111/j.1537-2995.2004.03422.x
[80] Scully M, Hunt BJ, Benjamin S, 
Liesner R, Rose P, Peyvandi F, et al. 
Guidelines on the diagnosis and 
management of thrombotic 
thrombocytopenic purpura and other 
thrombotic microangiopathies 
[Internet]. Vol. 158, British Journal of 
Haematology. 2012. p. 323-35. Available 
from: http://dx.doi.org/10.1111/j.1365- 
2141.2012.09167.x
[81] Pavord S, Myers B, Robinson S, 
Allard S, Strong J, Oppenheimer C, et al. 
UK guidelines on the management of 
iron deficiency in pregnancy. Br J 
Haematol. 2012 Mar;156(5):588-600.
[82] Bothwell TH. Iron requirements in 
pregnancy and strategies to meet them 
[Internet]. Vol. 72, The American 
Journal of Clinical Nutrition. 2000. p. 
257S – 264S. Available from: http://
dx.doi.org/10.1093/ajcn/72.1.257s
[83] Jacob A. Medical Disorders 
Associated with Pregnancy [Internet]. A 
Comprehensive Textbook of Midwifery. 




[84] Myers B. Diagnosis and 
management of maternal 
thrombocytopenia in pregnancy 
[Internet]. Vol. 158, British Journal of 
Haematology. 2012. p. 3-15. Available 
from: http://dx.doi.org/10.1111/j.1365- 
2141.2012.09135.x
[85] Provan D, Stasi R, Newland AC, 
Blanchette VS, Bolton-Maggs P, 
Bussel JB, et al. International consensus 
report on the investigation and 
management of primary immune 
thrombocytopenia [Internet]. Vol. 115, 
Blood. 2010. p. 168-86. Available from: 
http://dx.doi.org/10.1182/
blood-2009-06-225565
[86] Izak M, Bussel JB. Management of 
thrombocytopenia. F1000Prime Rep 
[Internet]. 2014 Jun 2 [cited 2021 May 
28];6(45). Available from: https://
facultyopinions.com/prime/
reports/m/6/45/pdf
[87] Greaves M, Letsky EA. Guidelines 
on the investigation and management of 
thrombocytopenia in pregnancy and 
neonatal alloimmune thrombocytopenia 
[Internet]. Vol. 104, BJOG: An 
International Journal of Obstetrics and 
Gynaecology. 1997. p. 1108-1108. 
Available from: http://dx.doi.
org/10.1111/j.1471-0528.1997.tb10931.x
